Tagged with Aetna
Aetna has issued a letter to providers detailing the steps the insurer is taking to ensure beneficiaries have access to testing and treatment for COVID-19.
Effective March 1, Aetna will implement code updates under which individual service codes will be assigned within contract service groupings. Changes to an individual provider’s compensation will depend on the presence or absence of specific service groupings within the contract.
Aetna has issued a reminder for patient and provider regarding coverage of certain experimental and investigational laboratory tests.
Aetna has issued a notice, informing providers that, at the end of this year, the insurer will adjust payment for multiple endoscopy procedures in the same family.
Aetna has released the latest updates to its National Precertification List, including updates to new-to-market drugs and site of care requirements.
Aetna has released the latest updates to its National Precertification List, scheduled to take effect this year through January 2020.
Effective July 1, Aetna will require prior authorization for certain procedures under its Enhanced Clinical Review Program with eviCore healthcare.
Beginning July 1, Aetna will require authorization for its enhanced clinical review program with eviCore healthcare for certain outpatient radiation therapy services.
Effective September 1, Aetna will require precertification is required for certain new-to-market drugs.
Aetna has released updates regarding how the insurer will handle certain ambulatory surgical center (ASC) and ambulatory payment classification (APC) code edits under the ASC and APC payment methodologies.
Aetna has posted updated information regarding how the insurer will handle certain Ambulatory Surgical Center (ASC) and Ambulatory Payment Classification (APC) code edits under the ASC and APC payment methodologies.
Effective April 1, Aetna will implement several updates to its pharmacy plan drug lists. These changes will affect all Pharmacy Management drug lists, precertification, quantity limits, and step-therapy programs.
Aetna has issued an update regarding the use of CPT II codes for HEDIS® high blood pressure measurements for patients diagnosed with hypertension.
Aetna has posted a reminder regarding provider contract termination requirements in the state of Connecticut.
Following its recent approval from the New York’s Department of Financial Services, the $69 billion merger between CVS Health Corp. and Aetna closed Wednesday, November 28. The two organizations say that the merger will immediately improve health-care outcomes and reduce costs.
On January 1, Aetna will make updates to certain products on its pharmacy plan drug lists, including such products as granulocyte colony-stimulating factor (G-CSF) and epoetin alfa products.
Aetna has released its most recent updates to its National Precertification List (NPL), as well as several clinical payment and coding policy changes set to take effect over the coming months.
Effective July 1, Aetna will update its pharmacy plan drug lists. These changes will affect all Pharmacy Management drug lists, precertification, quantity limits and step-therapy programs.
Effective July 1, Aetna will implement changes to its clinical payment and coding policies as well as several changes to its National Precertification List (NPL).
Aetna has issued a notice reminding providers and billing professionals that Medicare beneficiaries under the Qualified Medicare Beneficiary (QMB) program should not be billed for cost sharing (balanced billing).